QMS Medical

34
Sell
  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0FMW01018
  • NSEID: QMSMEDI
  • BSEID:
INR
90.40
-1.5 (-1.63%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 7000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 18.62% vs 17.38% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 27.11% vs 61.97% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 90.56% vs 36.60% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 15.75% vs 41.14% in Mar 2024

Compare Profit and Loss Results of QMS Medical
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
144.00
114.00
30.00
26.32%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
144.00
114.00
30.00
26.32%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-6.00
6.00
100.00%
Raw Materials Consumed
81.00
86.00
-5.00
-5.81%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
7.00
14.00
-7.00
-50.00%
Operating Expenses
6.00
0.00
6.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
10.00
-6.00
-60.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
1.00
13.00
1,300.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
121.00
124.00
-3.00
-2.42%
Operating Profit (PBDIT) excl Other Income
23.00
-9.00
32.00
355.56%
Other Income
0.00
12.00
-12.00
-100.00%
Operating Profit (PBDIT)
23.00
2.00
21.00
1,050.00%
Interest
5.00
1.00
4.00
400.00%
Profit before Depriciation and Tax
17.00
1.00
16.00
1,600.00%
Depreciation
3.00
2.00
1.00
50.00%
Profit Before Taxation & Exceptional Items
14.00
0.00
14.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
0.00
14.00
0%
Provision for Tax
4.00
0.00
4.00
0%
Profit After Tax
10.00
0.00
10.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
30.00
85.00
-55.00
-64.71%
Profit Available for appropriations
40.00
84.00
-44.00
-52.38%
Appropriations
40.00
84.00
-44.00
-52.38%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.84
-0.67
6.51
971.64%
Profit And Loss - Net Sales
Net Sales 144.87 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.62% vs 17.38% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.32 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 27.11% vs 61.97% in Mar 2024

Profit And Loss - Interest
Interest 5.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 90.56% vs 36.60% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.75% vs 41.14% in Mar 2024